Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005☆
Introduction
The Study of the Efficacy of Nosocomial Infection Control (SENIC) in US hospitals demonstrated that surveillance should be included in infection control activities to be effective.1 Subsequently, prevalence surveys of healthcare-associated infections (HAIs) have been performed in several European countries to define HAI control priorities.2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 In Finland, according to the Communicable Disease Law revised in 2004, all healthcare settings should have HAI prevention and control programmes. The infection control teams on healthcare district level have a consulting role in these activities. To support these regional and local infection control activities, the Finnish Hospital Infection Program (SIRO) has conducted prospective incidence surveillance on healthcare-associated bloodstream infections (BSIs) and surgical site infections (SSIs) since 1999. In the absence of nationwide prevalence surveys on HAIs in Finland, there have been no data to define the overall burden of HAIs at the national level.
The aim of this study was to assess the magnitude of HAI in Finnish acute care hospitals, distribution of HAI types, causative organisms, prevalence of predisposing factors and use of antimicrobial agents. We also aimed to improve the quality of the prevalence surveys in individual hospitals by providing a common protocol with standardised HAI definitions and training to support consistent implementation.
Section snippets
Methods
All acute care hospitals were invited to a voluntary survey by a letter to the chief executive officers and physicians responsible for communicable disease control in all 20 healthcare districts. All inpatients present on the study day on adult acute care wards were included, with the exception of those who were only on day visits. The survey was completed in each hospital between 2 February and 11 March 2005. Each ward was surveyed on a single day, preferring Tuesdays, Wednesdays and Thursdays
Results
The survey was performed in 30 acute care hospitals. All tertiary (N = 5) and secondary (N = 15) care hospitals took part in the survey, as well as 10 (25%) of the 40 other acute care hospitals (Table I). A total of 8234 patients were examined: 2759 (34%) had signs and/or symptoms of an infection or ongoing treatment for an infection on study day; 1824 (22%) had community-acquired infections; and there was a suspicion of HAI for 829 (10%).
A total of 753 HAIs were confirmed in 703 patients. The
Discussion
Our national prevalence survey, covering all specialties except paediatrics and psychiatry, provided a comprehensive picture of the HAI burden in Finnish acute care hospitals. The overall participation of hospitals was high (50%) and all tertiary and secondary care hospitals participated. On study day, 9% of patients had at least one HAI, of which nearly 30% were SSIs. The prevalence (2–20%) and types of HAIs varied widely between different specialties. A microbiological diagnosis was made in
References (26)
- et al.
Prevalence of nosocomial infection and infection control in Denmark
J Hosp Infect
(1980) - et al.
National prevalence survey of hospital-acquired infections in Italy, 1983
J Hosp Infect
(1986) - et al.
The national prevalence survey of nosocomial infections in Belgium, 1984
J Hosp Infect
(1987) - et al.
National prevalence survey of hospital-acquired infections in Czechoslovakia
J Hosp Infect
(1988) - et al.
Prevalence of nosocomial infections in representative German hospitals
J Hosp Infect
(1998) - et al.
Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level
J Hosp Infect
(2002) - et al.
Prevalence of and risk factors for hospital-acquired infections in Slovenia–results of the first national survey, 2001
J Hosp Infect
(2003) - et al.
The second national prevalence survey of infection in hospitals: methodology
J Hosp Infect
(1995) - et al.
Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000
J Hosp Infect
(2003) - et al.
Prevalence of nosocomial infections in Spain: EPINE study 1990–1997. EPINE Working Group
J Hosp Infect
(1999)
Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003
J Hosp Infect
CDC definitions
Am J Infect Control
An analysis of two prevalence surveys of nosocomial infection in German intensive care units
J Hosp Infect
Cited by (49)
Incidence of hospital-acquired influenza in adults: A prospective surveillance study from 2004 to 2017 in a French tertiary care hospital
2021, American Journal of Infection ControlChanges in health care-associated infection prevention practices in Japan: Results from 2 national surveys
2019, American Journal of Infection ControlPoint-prevalence survey of healthcare-associated infections in Beijing, China: A survey and analysis in 2014
2016, Journal of Hospital InfectionCitation Excerpt :In addition, HCAI surveillance standards and control measures affect their prevalence. Surveys conducted worldwide2–9 have demonstrated an inverse relationship between HCAIs and national prosperity, although the diagnostic criteria vary between countries. The surveillance standards in most countries incorporate the definitions and diagnostic criteria for healthcare-associated surveillance established by the US Centers for Disease Control and Prevention (CDC).10
Need for more targeted measures - Only less severe hospital-associated infections declined after introduction of an infection control program
2015, Journal of Infection and Public HealthIncidence of healthcare associated infection in the surgical ICU of a tertiary care hospital
2013, Medical Journal Armed Forces IndiaA return to the basics: " Interventional Patient Hygiene" (A call for papers)
2012, Intensive and Critical Care Nursing
- ☆
Abstract presented at the 10th European Programme for Intervention Epidemiology Training (EPIET) Scientific Seminar, Maó, Spain, 13–15 October 2005 and at the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA), Chicago, USA, 18–21 March 2006, as a poster; and the results of antimicrobial use in the Journal of Antimicrobial Chemotherapy 2007;60(2):440–444.